STIMU GH 50 micrograms, powder and solvent for solution for injection (IV) ampoule, 1 ml
Active ingredients: SOMATORÉLINE (ACÉTATE DE), Somatorelin
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder and solvent for solution for injectionampoule, 1 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- STIMU GH 50 microgrammes, poudre et solvant pour solution injectable (IV)
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 ampoule(s) en verre - 1 ampoule(s) en verre de 1 ml
- Marketing authorisation holder
- FERRING (FRANCE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 15 Sept 2022
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63031888CIP75572190CIP133400955721901Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SOMATORÉLINE BASEpoudre | 50 microgrammes · une ampoule | FT |
| SOMATORÉLINE (ACÉTATE DE)poudre | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.